To determine if changes in Gp100, MHC-I, and MHC-II expression could be attributed to T cell responses, we compared B16 tumors grown in normal B6 mice to those in transgenic OT-II recipients that have a severely limited T cell repertoire and should not recognize melanoma antigens (Fig. 4D). Here, PMEL is linked to melanoma.